Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study (Q33375086)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study |
scientific article |
Statements
1 reference
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study (English)
1 reference
K Rajender Reddy
1 reference
Sanjeev Arora
1 reference
David R Nelson
1 reference
Christopher O'Brien
1 reference
Yi Xu
1 reference
Brian Murphy
1 reference
1 reference
Identifiers
1 reference